Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer.
about
Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we haveCan Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancerBiomarkers in pancreatic adenocarcinoma: current perspectivesCirculating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic CancerKRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patientsK-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis.Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)Clinically Meaningful Use of Blood Tumor Markers in Oncology.KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-controlClinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.Connecting Effective Immune Response, Fluorescent Granzyme B-like Peptide, Specific Peptide Binding Patterns, Patients with Cancer and Viral Infection, in Remission, Clinical Significance, and Liquid Biopsy.Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer.The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis.Distribution of circulating tumor DNA in lung cancer: analysis of the primary lung and bone marrow along with the pulmonary venous and peripheral blood.A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative.Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer.Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma.Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis.Detection of tumor-derived DNA dispersed in the airway improves the diagnostic accuracy of bronchoscopy for lung cancer.Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA.Liquid biopsy in pancreatic cancer: the beginning of a new era.The Significance of Liquid Biopsy in Pancreatic CancerFragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancerThe Use of Biomarkers in Early Diagnostics of Pancreatic CancerUtility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients
P2860
Q26750944-8B045515-091C-4B50-BC4C-7ABAA527BEA2Q28066454-6EF150CF-A209-4EA7-9FF1-18E6CC748BEAQ28069755-843399E6-A15C-4C45-9AD4-270F17E3310BQ28072309-87BE819E-A7D2-449A-AB9F-362C30C2A79BQ28073765-D2F58F84-F8DF-465B-9E0B-DDAA83311FECQ28077570-F784C33C-046E-457B-8BCA-4BB764DAC7B1Q30250097-8D60466C-4EA9-41A8-9999-5C6ECA643A25Q34515855-B8620CEF-A089-45BB-80DE-9FDD8B877934Q37500722-800D84DC-330C-480E-B6CC-79FC09DF1E21Q37694710-B4901998-FDC9-4626-91ED-1D24A4059B76Q38726457-F80D0EE0-97B3-4FD2-B3F7-22D67B8B9B5BQ40476736-705578E8-3EBF-49DA-9D3A-D91081149395Q40495250-214BA661-8FA4-462A-867B-DD435911DF30Q41347759-2F38FC3E-D747-4496-B1E0-4F6FD5989DBFQ41708857-EF684F94-5147-42DE-A344-59797565CA79Q43763245-A3B4D341-3F36-43E0-90AD-CED41191C28EQ45901388-2688B7E3-281D-4D09-897B-81E0729DBC14Q46736806-70D0B926-4652-4EE6-8085-6B8123316A43Q47146321-F77E3077-A8B0-4CA7-BDA8-26203D35533FQ47157939-79B054EB-333C-4EC6-83B4-E5B244BA04D4Q47562193-F4DA27BC-5DE2-404B-92C5-94B26CBCFDDCQ50042439-2B8FBC68-B035-4DA2-AD5C-987A8E03336CQ55187959-48509075-7913-4C79-9C51-4C037E791759Q57116278-70744514-9B8D-4A95-934F-AF2639AE545BQ58607799-32CE18E4-5E0E-4479-AFF6-EA2554F949D4Q58780532-8628F601-F655-435A-8D2E-7497C048F94EQ58803568-BBBD36AB-A87C-47E4-901B-EB3CA8FCD233
P2860
Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical relevance of circulat ...... th advanced pancreatic cancer.
@en
type
label
Clinical relevance of circulat ...... th advanced pancreatic cancer.
@en
prefLabel
Clinical relevance of circulat ...... th advanced pancreatic cancer.
@en
P2093
P2860
P50
P1433
P1476
Clinical relevance of circulat ...... th advanced pancreatic cancer.
@en
P2093
Jon Arne Søreide
Katrine Steen-Ottosen Berry
Millind Javle
Morten Lapin
Satu Oltedal
P2860
P304
P356
10.1016/J.MOLONC.2015.11.012
P577
2015-12-15T00:00:00Z